PharmaCyte Biotech, Inc. (PMCB)
NASDAQ: PMCB · Real-Time Price · USD
1.640
0.00 (0.00%)
Dec 20, 2024, 4:00 PM EST - Market closed
PharmaCyte Biotech Market Cap
PharmaCyte Biotech has a market cap or net worth of $11.43 million as of December 20, 2024. Its market cap has decreased by -42.28% in one year.
Market Cap
11.43M
Enterprise Value
-9.41M
1-Year Change
-42.28%
Ranking
Category
Stock Price
$1.64
Market Cap Chart
Since January 2, 2013, PharmaCyte Biotech's market cap has decreased from $17.00M to $11.43M, a decrease of -32.78%. That is a compound annual growth rate of -3.26%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Dec 20, 2024 | 11.40M | -38.71% |
Dec 29, 2023 | 18.60M | -66.12% |
Dec 30, 2022 | 54.90M | 5.98% |
Dec 31, 2021 | 51.80M | 219.75% |
Dec 31, 2020 | 16.20M | -72.16% |
Dec 31, 2019 | 58.20M | 35.03% |
Dec 31, 2018 | 43.10M | -23.17% |
Dec 29, 2017 | 56.10M | -57.11% |
Dec 30, 2016 | 130.80M | 266.39% |
Dec 31, 2015 | 35.70M | -72.56% |
Dec 31, 2014 | 130.10M | 108.16% |
Dec 31, 2013 | 62.50M | 267.65% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AIM ImmunoTech | 12.12M |
STRATA Skin Sciences | 12.05M |
Imunon | 12.04M |
Sol-Gel Technologies | 11.95M |
Lyra Therapeutics | 11.78M |
Turnstone Biologics | 11.36M |
Sensei Biotherapeutics | 11.32M |
BiomX | 11.27M |